Quality of life instruments in Ménière's disease.

Quality of life instruments in Ménière's disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Quality of life instruments in Ménière's disease. Abstract Text:

J Douglas Green,Aimee Verrall,George A Gates,J Douglas Green,Aimee Verrall,George A Gates,

OBJECTIVE: Evaluate the sensitivity of quality of life (QoL) instruments over time in patients with Ménière's disease using general, symptom-specific, and disease-specific QoL instruments. STUDY DESIGN: Prospective study using QoL instruments administered serially over 4 months in patients undergoing treatment for Ménière's disease. METHODS: Sixty-one people aged 33 to 71 years with active, unilateral, cochleovestibular Ménière's disease refractory to medical management completed two general QoL instruments, Sense of Coherence (SOC) and World Health Organization Quality of Life-Abbreviated Version (WHOQOL-BREF), one symptom-specific QoL instrument, Vertigo Symptom Scale (VSS), and one disease-specific QoL instrument, Ménière's Disease Patient Oriented Severity Index (MDPOSI). All measures were administered at baseline and again 2 and 4 months later. RESULTS: Disease- and symptom-specific instruments including the MDPOSI and VSS were positively correlated with vertigo control category (Pearson's R=0.345, MDPOSI; 0.279, VSS), indicating sensitivity to the frequency of vertigo spells. These instruments were also sensitive to changes in vertigo over time. Standardized response means showed greatest responsiveness to change on the MDPOSI (0.80) and the VSS (0.79). Standardized response means for SOC and WHOQOL-BREF were 0.03, and 0.32, respectively, suggesting poor responsiveness to change of symptoms. The VSS and MDPOSI were highly correlated (Pearson's r coefficient 0.744; P<.001). CONCLUSIONS: A disease-specific QoL instrument such as the MDPOSI and a symptom-specific instrument such as the VSS more accurately reflect changes in control of vertigo in people with Ménière's disease over time than do general QoL instruments. These instruments can be used to determine the life impact of Ménière's disease and how aggressive therapy should be for the patient.

Quality of life instruments in Ménière's disease. Publishing Authors By Initials

JD Green,A Verrall,GA Gates,JD Green,A Verrall,GA Gates,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Quality of life instruments in Ménière's disease. Journal Published:

PUBLICATION TYPE: Validation Studies

Journal: The Laryngoscope

VOLUME: 117

Page Numbers: 1622-8

Journal Abbreviation: Laryngoscope

ISSN: 0023-852X

DAY: 24

MONTH: Sep

YEAR: 2007

Quality of life instruments in Ménière's disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8607378

Quality of life instruments in Ménière's disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Quality of life instruments in Ménière's disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Quality of life instruments in Ménière's disease.

AFFILIATION: Jacksonville Hearing and Balance Institute, Jacksonville, Florida 32207, USA. dougg@jhbi.org

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Laryngoscope

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Quality of life instruments in Ménière's disease Related Publications

• A chemical model for redox regulation of protein tyrosine phosphatase 1B (PTP1B) activity.
• A protocol for evaluation of lumbar diskectomy: a second study.
• Abstracts, American Chemical Society Division of Chemical Toxicology, 234th ACS National Meeting, Boston, MA, August 19-23, 2007.
• Body radium content of individuals with no known occupational exposure.
• Catalysis by supported gold: correlation between catalytic activity for CO oxidation and oxidation states of gold.
• Clinical quality improvement: getting physicians involved.
• DNA damage by fasicularin.
• DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2).
• Dr. Jeanne C. Sinkford.
• Effect of self-assembled monolayers (SAMs) in binding glucose oxidase for electro-enzymatic glucose sensor with gold electrodes.
• Entering the leinamycin rearrangement via 2-(trimethylsilyl)ethyl sulfoxides.
• Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
• Fragmentation studies of monensin A and B in negative electrospray and nanospray tandem mass spectrometry.
• Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous).
• Interstrand cross-links generated by abasic sites in duplex DNA.
• Interventions for the treatment of twin-twin transfusion syndrome.
• It Doesn't Happen Here: Eating Disorders in an Ethnically Diverse Sample of Economically Disadvantaged, Urban College Students.
• Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein.
• Metastatic mycotic abscesses of the brain.
• Primary operative management for pediatric empyema: decreases in hospital length of stay and charges in a national sample.
• Quality of life instruments in Ménière's disease.
• Radiography of glycogen storage diseases.
• Regeneration in an earthworm, Eisenia foetida (Savigny) 1826; anterior regeneration.
• Saving the world is within our grasp.
• Small molecules that mimic the thiol-triggered alkylating properties seen in the natural product leinamycin.
• Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
• The role of experience in liking "read-to-drink" alcoholic beverages.
• This issue.
• Venographic findings at retrieval of inferior vena cava filters.
• [Sinusitis in childhood]